Relationships Between Chemotherapy, Chemotherapy Dose Intensity and Outcomes of Follicular Lymphoma in the Immunochemotherapy Era: A Report from the University of Iowa/Mayo Clinic SPORE Molecular Epidemiology Resource

The optimal treatment of follicular lymphoma (FL) is not established. Rituximab is an important component of FL treatment making the impact of chemotherapy on FL less clear. We reviewed 649 FL at the University of Iowa/Mayo Clinic from 2002 to 2009 looking for the association of total dose delivery...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Leuk Lymphoma
Autors principals: Wudhikarn, K., Smith, B. J., Button, A. M., Habermann, T. M., Thompson, C. A., Rosenstein, L. J., Syrbu, S. I., Weiner, G. J., Cerhan, J. R., Link, B. K.
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4530103/
https://ncbi.nlm.nih.gov/pubmed/25530345
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2014.994206
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars